DRW Securities’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

DRW Securities’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-43,000	Closed	-$545K	–	492
2017 Q3	$545K	Buy	+43,000	New	+$547K	0.44%	28
2016 Q2	–	Sell	-140,450	Closed	-$2.33M	–	120
2016 Q1	$2.33M	Buy	140,450 +109,450	+353%	+$1.92M	0.75%	28
2015 Q4	$672K	Buy	+31,000	New	+$603K	0.36%	40
2015 Q3	–	Sell	-43,500	Closed	-$1.51M	–	140
2015 Q2	$1.51M	Sell	43,500 -235,500	-84%	-$7.19M	1.37%	27
2015 Q1	$7.25M	Buy	279,000 +190,990	+217%	+$3.5M	4.96%	11
2014 Q4	$1.13M	Buy	+88,010	New	+$1.1M	0.46%	53
2014 Q1	–	Sell	-20,000	Closed	-$152K	–	276
2013 Q4	$152K	Buy	+20,000	New	+$108K	0.05%	196

Other funds holding HZNP

Scopia Capital Management New York $144M AUM 25.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

William Blair Investment Management

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Brandywine Global Investment Management Philadelphia, Pennsylvania $14.9B AUM 20.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return